NASDAQ : WHWK

Whitehawk Therapeutics, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 3.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 188.13M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Details

NameWhitehawk Therapeutics, Inc.
SectorHealthcare
IndustryBiotechnology
Employees32
Founded2007
CeoDavid Lennon
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS00032Q1040
Cusip00032Q104
Cik0001422142
Sic2834
Stock TypeCommon Stock

Key executives

NameTitle
Dr. David J. Lennon Ph.D.President, Chief Executive Officer and Director
Dr. Neil P. Desai Ph.D.Founder and Director
Scott M. Giacobello CPAChief Financial Officer, Treasurer, Investor Relations and Corporate Communications
Bryan BallChief Technical Operations Officer
Dr. David Dornan Ph.D.Chief Scientific Officer
Stephen M. Rodin J.D.Senior Vice President of Legal and General Counsel
Dr. Margaret Han Dugan M.D.Chief Medical Officer

Contact

Address2 Headquarters Plaza, East Building, Morristown, New Jersey 07960, United States
Phone551 321 2234
Websitehttps://ir.whitehawktx.com